FDA/EUA Authorized Rapid Test Kits

PRODUCT INFORMATION


    FDA/EUA Authorized for point-of-care testing

    Detect SARS-CoV-2 Virus

    Rapid Results

    ~15 minutes

    95% Relative Sensitivity

    Antigen test is based on lateral-flow

    immunochromatographic assay and

    does not require additional  equipment

    for detection or analyses. The test

    detects antigens specific to SARS-CoV-2

    in nasopharyngeal specimens collected

    from individuals suspected of being

    infected with COVID-19 or exposed

    to COVID-19.

    COVID-19 Antibody Rapid Test

    is a lateral flow in-vitro

    immunoassay intended to detect the

    presence of SARS-CoV-2 IgM and IgG antibodies

    from a whole blood sample (usually finger prick).

      These antibodies develop in our body

      in response to a previous

    infection  by SARS-CoV-2

    or in response to vaccination.

    Accula Rapid test kit is FDA approved

    SARS-Cov-2 test using polymerase chain

    reaction (PCR) and lateral flow technologies.

    Accula is a molecular in vitro diagnostic

    test for the qualitative and visual detection

    of nucleic acid from SARS-CoV-2 virus.

    Samples are either in nasal or nasal

    mid-turbinate swab specimens or

    self-collected on site nasal swabs.

    Inquire Now

    Please chat with us if you are ordering from the U.S. today, COVID-19 Rapid Test Kits available with volume discounts.

    Email: rapidresponse@aurorabiomed.com

    TEL: 360-820-1331